Diego Fuentes

Diego Fuentes

Auto-generated profile, based on publicly available information

Diego Fuentes

Barcelona Supercomputing Center (BSC-CNS) , 08034 Barcelona

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Genome Biology and Evolution
Verified
Journal Article
Open access
PDF file
FLFelix Langschied
Felix Langschied
NBNicola Bordin
Nicola Bordin
SCSalvatore Cosentino
Salvatore Cosentino
DFDiego Fuentes-Palacios
Diego Fuentes-Palacios
NGNatasha Glover
Natasha Glover
Ingo EbersbergerIngo Ebersberger
Ingo Ebersberger
The era of biodiversity genomics is characterized by large-scale genome sequencing efforts that aim to represent each living taxon with an assembled genome. Generating knowledge from this wealth of data has not kept up with this pace. We here discuss major challenges to integrating these novel genomes into a comprehensive functional and evolutionary network spanning the tree of life. In summary, the expanding datasets create a need for scalable gene annotation methods. To trace gene function across species, new methods must seek to increase the resolution of ortholog analyses, e.g. by extending analyses to the protein domain level and by accounting for alternative splicing. Additionally, the scope of orthology prediction should be pushed beyond well-investigated proteomes. This demands the development of specialized methods for the identification of orthologs to short proteins and noncoding RNAs and for the functional characterization of novel gene families. Furthermore, protein structures predicted by machine learning are now readily available, but this new information is yet to be integrated with orthology-based analyses. Finally, an increasing focus should be placed on making orthology assignments adhere to the findable, accessible, interoperable, and reusable (FAIR) principles. This fosters green bioinformatics by avoiding redundant computations and helps integrating diverse scientific communities sharing the need for comparative genetics and genomics information. It should also help with communicating orthology-related concepts in a format that is accessible to the public, to counteract existing misinformation about evolution.

13 February 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
AAAmir Arastehfar
Amir Arastehfar
NÜNevzat Ünal
Nevzat Ünal
THTuğrul Hoşbul
Tuğrul Hoşbul
MÖMuhammed Alper Özarslan
Muhammed Alper Özarslan
AKAyşe Sultan Karakoyun
Ayşe Sultan Karakoyun
MNM Hong Nguyen
M Hong Nguyen
We evaluated the epidemiology of candidemia among coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). We conducted a retrospective multicenter study in Turkey between April and December 2020. Twenty-eight of 148 enrolled patients developed candidemia, yielding an incidence of 19% and incidence rate of 14/1000 patient-days. The probability of acquiring candidemia at 10, 20, and 30 days of ICU admission was 6%, 26%, and 50%, respectively. More than 80% of patients received antibiotics, corticosteroid, and mechanical ventilation. Receipt of a carbapenem (odds ratio [OR] = 6.0, 95% confidence interval [CI] = 1.6–22.3, P = .008), central venous catheter (OR = 4.3, 95% CI = 1.3–14.2, P = .02), and bacteremia preceding candidemia (OR = 6.6, 95% CI = 2.1–20.1, P = .001) were independent risk factors for candidemia. The mortality rate did not differ between patients with and without candidemia. Age (OR = 1.05, 95% CI = 1.01–1.09, P = .02) and mechanical ventilation (OR = 61, 95% CI = 15.8–234.9, P < .0001) were independent risk factors for death. Candida albicans was the most prevalent species overall. In Izmir, Candida parapsilosis accounted for 50% (2 of 4) of candidemia. Both C parapsilosis isolates were fluconazole nonsusceptible, harbored Erg11-Y132F mutation, and were clonal based on whole-genome sequencing. The 2 infected patients resided in ICUs with ongoing outbreaks due to fluconazole-resistant C parapsilosis. Physicians should be aware of the elevated risk for candidemia among patients with COVID-19 who require ICU care. Prolonged ICU exposure and ICU practices rendered to COVID-19 patients are important contributing factors to candidemia. Emphasis should be placed on (1) heightened infection control in the ICU and (2) developing antibiotic stewardship strategies to reduce irrational antimicrobial therapy.

26 April 2023 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
FDFarnaz Daneshnia
Farnaz Daneshnia
SHSüleyha Hilmioğlu-Polat
Süleyha Hilmioğlu-Polat
Macit IlkitMacit Ilkit
Macit Ilkit
DFDiego Fuentes
Diego Fuentes
LLLisa Lombardi
Lisa Lombardi
AAAmir Arastehfar
Amir Arastehfar
Although perceived as a rare clinical entity, recent studies have noted the emergence of MDR C. parapsilosis (MDR-Cp) isolates from single patients (resistant to both azole and echinocandins). We previously reported a case series of MDR-Cp isolates carrying a novel FKS1R658G mutation. Herein, we identified an echinocandin-naive patient infected with MDR-Cp a few months after the previously described isolates. WGS and CRISPR-Cas9 editing were used to explore the origin of the new MDR-Cp isolates, and to determine if the novel mutation confers echinocandin resistance. WGS was applied to assess the clonality of these isolates and CRISPR-Cas9 editing and a Galleria mellonella model were used to examine whether FKS1R658G confers echinocandin resistance. Fluconazole treatment failed, and the patient was successfully treated with liposomal amphotericin B (LAMB). WGS proved that all historical and novel MDR-Cp strains were clonal and distant from the fluconazole-resistant outbreak cluster in the same hospital. CRISPR-Cas9 editing and G. mellonella virulence assays confirmed that FKS1R658G confers echinocandin resistance in vitro and in vivo. Interestingly, the FKS1R658G mutant showed a very modest fitness cost compared with the parental WT strain, consistent with the persistence of the MDR-Cp cluster in our hospital. Our study showcases the emergence of MDR-Cp isolates as a novel threat in clinical settings, which undermines the efficacy of the two most widely used antifungal drugs against candidiasis, leaving only LAMB as a last resort. Additionally, surveillance studies and WGS are warranted to effectively establish infection control and antifungal stewardship strategies.

7 October 2022 in GigaScience
Verified
Journal Article
Open access
PDF file
MNMiguel A Naranjo-Ortiz
Miguel A Naranjo-Ortiz
MMManu Molina
Manu Molina
DFDiego Fuentes
Diego Fuentes
VMVerónica Mixão
Verónica Mixão
TGToni Gabaldon
Toni Gabaldon
Recent technological developments have made genome sequencing and assembly highly accessible and widely used. However, the presence in sequenced organisms of certain genomic features such as high heterozygosity, polyploidy, aneuploidy, heterokaryosis, or extreme compositional biases can challenge current standard assembly procedures and result in highly fragmented assemblies. Hence, we hypothesized that genome databases must contain a nonnegligible fraction of low-quality assemblies that result from such type of intrinsic genomic factors. Here we present Karyon, a Python-based toolkit that uses raw sequencing data and de novo genome assembly to assess several parameters and generate informative plots to assist in the identification of nonchanonical genomic traits. Karyon includes automated de novo genome assembly and variant calling pipelines. We tested Karyon by diagnosing 35 highly fragmented publicly available assemblies from 19 different Mucorales (Fungi) species. Our results show that 10 (28.57%) of the assemblies presented signs of unusual genomic configurations, suggesting that these are common, at least for some lineages within the Fungi.

23 October 2025 in bioRxiv
Verified
Preprint
Open access
VDVerónica A. Dubois
Verónica A. Dubois
MMMarina Marcet-Hoiben
Marina Marcet-Hoiben
DFDiego Fuentes-Palacios
Diego Fuentes-Palacios
EKEwa Ksiezopolska
Ewa Ksiezopolska
LGLAURA ALEJANDRA GLIOSCA
LAURA ALEJANDRA GLIOSCA
TGToni Gabaldon
Toni Gabaldon
The opportunistic yeast pathogen Candida dubliniensis is frequently misidentified as its closest relative Candida albicans , due to their high phenotypic similarity. Although Candida dubliniensis is an important cause of fungal infections, especially in the oral cavities of immunocompromised patients, its phenotypic and genomic variability remains poorly understood. We addressed this knowledge gap by performing a comprehensive phenotypic and genomic characterization of 33 C. dubliniensis oral isolates from people living with HIV in Argentina. Our results uncovered significant phenotypic heterogeneity—observed both inter- and intra-patient—impacting clinically relevant traits such as drug susceptibility, stress sensitivity, filamentation, and hypoxic growth. Our isolates expanded the previously known MLST-based genetic diversity of the species. Leveraging whole-genome sequencing, we resolved intricate evolutionary relationships, proposed a more robust MLST scheme for future typing, and identified potential antifungal resistance-causing variants. Collectively, this work represents the most comprehensive population genomics characterization of C. dubliniensis to date, establishing a foundation for improved surveillance and diagnostic strategies to fully define its role in both oral and systemic infections. Author Summary: In this study we uncover hidden genetic and morphological diversity in Candida dubliniensis, a poorly known opportunistic yeast pathogen related to Candida albicans , by characterising a collection of oral isolates from persons living with HIV in Argentina. Our findings provide the most detailed genetic and phenotypic snapshot of this pathogen to date, providing a much-needed foundation to develop better diagnostic tools and effective surveillance strategies to address infections caused by this overlooked threat.